Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Limitations of "classic" risk factors to predict neoadjuvant chemotherapy response for operable breast cancer.

× No keyword cloud information.

11 in total

1. HER2 and response to paclitaxel in node-positive breast cancer.

Authors: Dimitrios H Roukos
Journal: N Engl J Med Date: 2008-01-10 Impact factor: 91.245

2. Linking contralateral breast cancer with genetics.

Authors: Dimitrios H Roukos
Journal: Radiother Oncol Date: 2008-01-30 Impact factor: 6.280

3. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer.

Authors: Dimitrios H Roukos
Journal: J Clin Oncol Date: 2009-02-02 Impact factor: 44.544

4. Genomics and challenges toward personalized breast cancer local control.

Authors: Dimitrios H Roukos; Efstathios Lykoudis; Theodore Liakakos
Journal: J Clin Oncol Date: 2008-09-10 Impact factor: 44.544

5. Breast-cancer stromal cells with TP53 mutations.

Authors: Dimitrios H Roukos
Journal: N Engl J Med Date: 2008-04-10 Impact factor: 91.245

6. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations.

Authors: Dimosthenis Ziogas; Georgios Baltogiannis; Michael Fatouros; Dimitrios H Roukos
Journal: Ann Surg Date: 2008-04 Impact factor: 12.969

7. Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer.

Authors: Tadahiko Shien; Sadako Akashi-Tanaka; Kunihisa Miyakawa; Takashi Hojo; Chikako Shimizu; Kunihiko Seki; Masashi Ando; Tsutomu Kohno; Naruto Taira; Hiroyoshi Doihara; Noriyuki Katsumata; Yasuhiro Fujiwara; Takayuki Kinoshita
Journal: World J Surg Date: 2009-01 Impact factor: 3.352

8. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery.

Authors: Dimitrios H Roukos
Journal: Expert Rev Mol Diagn Date: 2008-09 Impact factor: 5.225

Review 9. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.

Authors: Michael Fatouros; Georgios Baltoyiannis; Dimitrios H Roukos
Journal: Ann Surg Oncol Date: 2007-10-17 Impact factor: 5.344

Review 10. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.

Authors: Dimitrios H Roukos
Journal: Expert Rev Mol Diagn Date: 2008-01 Impact factor: 5.225